Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Novartis reported $2.86B in Operating Profit for its fiscal quarter ending in March of 2023.

Operating Profit Change
AbbVie ABBV:US USD 2.77B 2.73B
Alcon AG ALC:SW USD 268M 247M
Almirall SA ALM:SM EUR -946000 48.76M
Amgen AMGN:US USD 2.03B 196M
Artemis Alpha ATS:LN GBP -16578000 10.12M
AstraZeneca AZN:LN USD 2.55B 1.46B
Bayer BAYN:GR EUR 2.97B 1.54B
Biogen BIIB:US USD 507.7M 192.2M
Bristol-Myers Squibb BMY:US USD 3.1B 1.15B
Eli Lilly LLY:US USD 1.49B 342.4M
Fresenius FRE:GR EUR 787M 100M
Fresenius Medical Care FME:GR EUR 261M 90.93M
Galapagos GLPG:NA EUR 21.97M 154.43M
Genmab GEN:DC DKK 437M 2.23B
Gilead Sciences GILD:US USD 1.7B 562M
GlaxoSmithKline GSK:LN GBP 2.08B 215M
Hikma Pharmaceutical HIK:LN USD 60M 189M
J&J JNJ:US USD -737000000 4.94B
Lonza Group LONN:SW CHF 896M 251M
Merck & Co MRK:US USD 3.72B 286M
Novartis NOVN:VX USD 2.86B 907M
Novartis NVS:US USD 2.86B 907M
Orion ORNBV:FH EUR 55.5M 14.8M
Pfizer PFE:US USD 6.79B 1.62B
Philips PHIA:NA EUR -583000000 754M
Recordati REC:IM EUR 173.41M 81.87M
Regeneron Pharmaceuticals REGN:US USD 946.7M 200.1M
Roche Holding ROG:VX CHF 5.93B 5.62B